Celularity
CELU
30 hedge funds and large institutions have $4.38M invested in Celularity in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 14 closing their positions.
1,427% more call options, than puts
Call options by funds: $229K | Put options by funds: $15K
113% more capital invested
Capital invested by funds: $2.06M → $4.38M (+$2.32M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
3.45% more ownership
Funds ownership: 0.44% → 3.89% (+3.5%)
19% less funds holding
Funds holding: 37 → 30 (-7)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$151K |
| 2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$144K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$74K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$55.6K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$53.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$224K |
| 2 |
BFO
Biltmore Family Office
Charlotte,
North Carolina
|
-$87.8K |
| 3 |
Millennium Management
New York
|
-$61.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.5K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$10K |
CELU Hedge Fund Activity: Q1 2024 in Review
30 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2024, worth a combined $4.38M — up 113% from $2.06M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CELU and 7 opened new positions — a net loss of 7 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Geode Capital Management, adding an estimated $151K. The largest seller was Renaissance Technologies, cutting an estimated $224K.
- 30 institutional investors held Celularity (CELU) as of Q1 2024, down from 37 in Q4 2023.
- Funds reported $4.38M of Celularity stock for Q1 2024, up 113% quarter-over-quarter.
- 7 funds opened new Celularity positions in Q1 2024 and 14 closed out, a net change of -7 holders.
- The largest Celularity buyer in Q1 2024 was Geode Capital Management, an estimated $151K added.
- The largest Celularity seller in Q1 2024 was Renaissance Technologies, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2024.